Luis Alvarez

Form D signer

Luis Alvarez

President at Theradaptive

Form D signer

Capital raised by Theradaptive

$36.2M+$36.2M latest round

1 Form D filing · first filed Jul 2026 · Frederick, MD

CURRENT ROLE: President
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

TheradaptiveBiotech · Frederick, MDsince Jul 2026

President

Signatory on Theradaptive's Form D filings · $36.2M raised across 1

Company filings

via EDGAR · Form D for Theradaptive1

DateCompanyFormAmountRole on filing

Jul 21, 2026TheradaptiveForm D+$36.2MPresident

Form DJul 21, 2026 · Theradaptive+$36.2Mas President

Overview

Last filing Jul 21, 2026

Luis Alvarez is on file as President at Theradaptive in Frederick, MD. Theradaptive has 1 Form D filing on record, $36.2M raised in total. Luis Alvarez appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Theradaptive · 1

Jeffrey DunnDirector

Products

Theradaptive · 1

OsteoAdapt SPClinical-stage regenerative biologic

An investigational bone graft therapeutic powered by AMP2, a proprietary rhBMP-2 variant engineered for targeted, sustained bone regeneration. It is being developed as an alternative to autologous and allograft bone in lumbar spinal fusion, and is in the pivotal OASIS trial after FDA approval in April 2026 to advance from feasibility to a pivotal study.